SpaceX’s stock falls as Wall Street gets spooked by the extent of AI spending
Morgan Stanley expects $64 billion in capital spending from SpaceX this year. The company is dramatically ramping up AI investments. Source：MarketWatch
Nvidia’s stock is basking in the glow of a high-profile endorsement
SpaceX CEO Elon Musk said his company will only use Nvidia’s chips to build its AI. Source：MarketWatch
Shopify’s stock heads for best day in a year after the company ‘left no doubt’ about its growth trajectory
The company is keeping costs in check while signaling upbeat growth trends, analysts say. Source：MarketWatch
It’s the worst time in years to invest in AI credit markets: ‘Almost no upside and plenty of downside’
Researchers at Andromeda Capital Management are worried about the uncertain return on investment for investors who are financing the AI capex bonanza.…
U.S. economy keeps up the momentum, but rising costs put a cap on new hiring
The largest part of the economy grew in July at a robust pace, but scattered shortages of key supplies and dogged inflation raised the cost of business and…
3 reasons AMD’s stock is falling in the face of its latest earnings report
Analysts noted that the company delivered muted upside with its results, underwhelmed some investors with its margin outlook and was simply up against high…
ADP says businesses add the fewest new jobs in six months. Labor market is still sluggish.
ADP said U.S. businesses created just 44,000 new jobs in July — the smallest increase in six months — in another sign of a sluggish labor market in which…
Uber profit narrowly beat forecasts as trips across its platform surge
Uber Technologies shares fell early Wednesday, despite the ridehailing company registering earnings a tad above Wall Street estimates in the second quarter as…
Walt Disney’s stock climbs as company cites ‘Toy Story 5’ for earnings growth
Walt Disney’s stock, which has been struggling all year, rallied on Wednesday as the entertainment giant reported surprisingly strong earnings.…
Reports of the 60/40 portfolio’s demise are proving to be premature
The balanced stockbond portfolio is defying the widespread argument that it is no longer an appropriate approach. Source：MarketWatch
Lilly’s revenue soars 48%, driven by demand for its GLP-1s
Lilly’s sales were driven by higherthanexpected demand for Mounjaro and Zepbound, its GLP1 drugs for Type 2 diabetes and weight loss. Source：MarketWatch
Is it a bad time to buy a home? Buyers say yes, data shows.
More people are hitting pause on buying a home, as surging mortgage rates continue to hinder the housing market. Source：MarketWatch